Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07866261
NA
Transconjunctival Versus Transcutaneous Betamethasone for Upper Eyelid Retraction in TED
Sponsor: Assiut University
View on ClinicalTrials.gov
Summary
This randomized controlled trial aims to compare the efficacy and safety of transconjunctival versus transcutaneous perilevator betamethasone injection in reducing upper eyelid retraction in patients with thyroid eye disease.
Official title: Transconjunctival Versus Transcutaneous Perilevator Betamethasone Injection for the Management of Thyroid Eye Disease-Related Upper Eyelid Retraction
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
54
Start Date
2026-10-10
Completion Date
2028-03-01
Last Updated
2026-10-08
Healthy Volunteers
No
Conditions
Interventions
DRUG
Betamethasone
Betamethasone suspension 1 mL injected into the perilevator space.